A critical advance in cancer study is arising with the use of VHH fragments to re-engage dysfunctional p53. This crucial cancer inhibitor protein is frequently lost in several types of cancer, leading uncontrolled https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research